82 FR 12610 - Agency Information Collection Activities; Proposed Collection; Public Comment Request; Extension of a Currently Approved Information Collection (ICR-REV); Centers for Independent Living Annual Performance Report (CILPPR); Correction
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Administration for Community Living Federal Register Volume 82, Issue 42 (March 6, 2017)
Administration for Community Living
Federal Register Volume 82, Issue 42 (March 6, 2017)
| Page Range | 12610-12611 | |
| FR Document | 2017-04169 |
[Federal Register Volume 82, Number 42 (Monday, March 6, 2017)] [Notices] [Pages 12610-12611] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2017-04169] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Administration for Community Living Agency Information Collection Activities; Proposed Collection; Public Comment Request; Extension of a Currently Approved Information Collection (ICR-REV); Centers for Independent Living Annual Performance Report (CILPPR); Correction AGENCY: Independent Living Administration, Administration for Community Living, HHS. ACTION: Notice of correction. ----------------------------------------------------------------------- SUMMARY: The Administration for Community Living published a proposed collection of information document in the Federal Register on February 23, 2017. (82 FR 11471 and 11472) The document contained an incorrect date and email address. In addition under the heading ``New Requirements'', the first paragraph was revised. FOR FURTHER INFORMATION CONTACT: Corinna Styles, 202-795-7446. Corrections: Under the DATES section, page 11471, column two, correct the notice to read: ``Submit written or electronic comments [[Page 12611]] on the collection of information by May 5, 2017.'' Under the ADDRESSES section, page 11471, column two, correct the notice to read: ``Submit electronic comments on the collection of information to: [email protected]''. Under the heading ``New Requirements'', the first paragraph, page 11472, column one, replace the first paragraph with the following paragraph below: ``The Workforce Innovation and Opportunity Act (WIOA), enacted on July 22, 2014, added a new core service to the list of ``independent living core services'' that ACL funded Centers for Independent Living (CILs) are required to provide. Prior to WIOA, CILs were required to provide the following core services: (1) Information and referral services; (2) independent living skills training; (3) peer counseling, including cross-disability peer counseling; (4) and individual and systems advocacy. WIOA added additional ``transition and diversion'' core services comprised of three components. It requires CILs to:''. Dated: February 24, 2017. Daniel P. Berger, Acting Administrator and Assistant Secretary for Aging. [FR Doc. 2017-04169 Filed 3-3-17; 8:45 am] BILLING CODE 4154-01-P
![12610 Federal Register / Vol. 82, No. 42 / Monday, March 6, 2017 / Notices
Studies where differences in potassium sectional studies or surveys, and case Telephone: 202–795–7334. Fax: 202–
intake or values are confounded with reports will be excluded. 795–7334. Email: Allison.Cruz@
alteration of other nutrient levels will be acl.hhs.gov.
Sharon B. Arnold,
excluded. SUPPLEMENTARY INFORMATION: The
Acting AHRQ Director.
IV. Outcomes [FR Doc. 2017–04193 Filed 3–3–17; 8:45 am]
PCPID acts in an advisory capacity to
the President and the Secretary of
BILLING CODE 4160–90–P
A. Studies reporting on mortality (all- Health and Human Services on a broad
cause, CVD, CHD, or renal); range of topics relating to programs,
cardiovascular disease morbidity, DEPARTMENT OF HEALTH AND services and support for individuals
including coronary heart disease (CHD), HUMAN SERVICES with intellectual disabilities. The PCPID
acute coronary syndrome (unstable executive order stipulates that the
angina and myocardial infarction), Administration for Community Living Committee shall: (1) Provide such
stroke, myocardial infarction (ST- advice concerning intellectual
segment elevation myocardial infarction Administration on Intellectual and disabilities as the President or the
[STEMI] and non-ST elevation Developmental Disabilities, President’s Secretary of Health and Human Services
myocardial infarction [NSTEMI]), Committee for People With Intellectual may request; and (2) provide advice to
requiring coronary revascularization Disabilities the President concerning the following
procedures (angioplasty, coronary stent for people with intellectual disabilities:
AGENCY: Administration for Community (A) Expansion of educational
placement, coronary artery bypass), Living, HHS. opportunities; (B) promotion of
other atherosclerotic revascularization ACTION: Notice. homeownership; (C) assurance of
procedures (carotid endarterectomy),
workplace integration; (D) improvement
left ventricular hypertrophy, DATES: Thursday, March 23, 2017 from of transportation options; (E) expansion
hospitalization for heart failure, or 8:30 a.m. to 5:00 p.m.; and Friday, of full access to community living; and
hospitalization for any cause of March 24, 2017 from 9:00 a.m. to 3:00 (F) increasing access to assistive and
coronary heart disease or cardiovascular p.m. universally designed technologies.
disease, or combined CVD morbidity These meetings will be open to the
and mortality; or reporting on renal general public. Dated: February 27, 2017.
function intermediary and clinical Bob Williams,
ADDRESSES: These meetings will be held
outcomes including creatinine clearance in U.S. Department of Health and Acting Designated Federal Official, PCPID,
(CrCl), serum creatinine (SCr), Administration on Disabilities (AoD).
Human Services/Hubert H. Humphrey
glomerular filtration rate (GFR), end [FR Doc. 2017–04165 Filed 3–3–17; 8:45 am]
Building located at 200
stage renal disease, chronic kidney IndependenceAvenue SW., Conference BILLING CODE 4154–01–P
disease (CKD), albuminuria/proteinuria Room 705A, Washington, DC 20201.
(including urine albumin-to-creatinine Individuals who would like to
DEPARTMENT OF HEALTH AND
ratio, urine albumin dipstick level, participate via conference call may do
HUMAN SERVICES
urine protein-to-creatinine ratio, so by dialing toll-free #: 1–800–779–
albumin excretion rate), kidney stone 4694, when prompted enter pass code: Administration for Community Living
incidence, or acute kidney injury will be 4511687. Individuals whose full
eligible. Studies that do not report participation in the meeting will require Agency Information Collection
baseline data on the outcomes of special accommodations (e.g., sign Activities; Proposed Collection; Public
interest will be excluded. language interpreting services, assistive Comment Request; Extension of a
listening devices, materials in Currently Approved Information
V. Timing alternative format such as large print or Collection (ICR–REV); Centers for
A. Studies reporting exclusively on Braille) should notify Ms. Allison Cruz, Independent Living Annual
Director, Office of Innovation, via email Performance Report (CILPPR);
kidney stone formation need to follow
at Allison.Cruz@acl.hhs.gov, or via Correction
participants for at least five years,
telephone at 202–795–7334, no later
studies reporting exclusively on kidney AGENCY: Independent Living
than Monday, March 6, 2017. The
disease need to follow participants for at Administration, Administration for
PCPID will attempt to accommodate
least two years, studies reporting Community Living, HHS.
requests made after this date, but cannot
exclusively on cardiovascular disease or guarantee the ability to grant requests ACTION: Notice of correction.
stroke need to follow patients for at least received after the deadline. All meeting
12 months; all other studies need to SUMMARY: The Administration for
sites are barrier free, consistent with the Community Living published a
report on an exposure period of at least Americans with Disabilities Act (ADA)
four weeks to be eligible. proposed collection of information
and the Federal Advisory Committee document in the Federal Register on
VI. Setting Act (FACA). February 23, 2017. (82 FR 11471 and
AGENDA: The Committee Members will 11472) The document contained an
A. Studies in community-dwelling discuss preparation of the PCPID 2017 incorrect date and email address. In
participants will be eligible. Report to the President, including its addition under the heading ‘‘New
asabaliauskas on DSK3SPTVN1PROD with NOTICES
VII. Study Design content and format, and related data Requirements’’, the first paragraph was
collection and analysis required to revised.
A. Prospective cohort studies and complete the writing of the Report. FOR FURTHER INFORMATION CONTACT:
nested case-control studies, where at ADDITIONAL INFORMATION: For further Corinna Styles, 202–795–7446.
least two groups are compared based on information, please contact Ms. Allison Corrections:
measured potassium intake or Cruz, Director, Office of Innovation, 330 Under the DATES section, page 11471,
biomarker values will be eligible. C Street SW., Switzer Building, Room column two, correct the notice to read:
Retrospective studies, case series, cross- 1114, Washington, DC 20201. ‘‘Submit written or electronic comments
VerDate Sep<11>2014 19:24 Mar 03, 2017 Jkt 241001 PO 00000 Frm 00078 Fmt 4703 Sfmt 4703 E:\FR\FM\06MRN1.SGM 06MRN1](https://thefederalregister.org/doc/82_FR_12652/page/1.svg)
![Federal Register / Vol. 82, No. 42 / Monday, March 6, 2017 / Notices 12611
on the collection of information by May SUPPLEMENTARY INFORMATION for Written/Paper Submissions
5, 2017.’’ instructions). Submit either electronic Submit written/paper submissions as
Under the ADDRESSES section, page or written comments on the public follows:
11471, column two, correct the notice to meeting by July 5, 2017. Late, untimely • Mail/Hand delivery/Courier (for
read: ‘‘Submit electronic comments on filed comments will not be considered. written/paper submissions): Division of
the collection of information to: Electronic comments must be submitted Dockets Management (HFA–305), Food
cilpprcomments@acl.hhs.gov’’. on or before July 5, 2017. The https:// and Drug Administration, 5630 Fishers
Under the heading ‘‘New www.regulations.gov electronic filing Lane, Rm. 1061, Rockville, MD 20852.
Requirements’’, the first paragraph, page system will accept comments until • For written/paper comments
11472, column one, replace the first midnight Eastern Time at the end of July submitted to the Division of Dockets
paragraph with the following paragraph 5, 2016. Comments received by mail/ Management, FDA will post your
below: hand delivery/courier (for written paper comment, as well as any attachments,
‘‘The Workforce Innovation and submissions) will be considered timely except for information submitted,
Opportunity Act (WIOA), enacted on July 22, if they are postmarked or the delivery marked and identified, as confidential,
2014, added a new core service to the list of service acceptance receipt is on or if submitted as detailed in
‘‘independent living core services’’ that ACL before that date. See the SUPPLEMENTARY ‘‘Instructions.’’
funded Centers for Independent Living (CILs) INFORMATION section for registration date Instructions: All submissions received
are required to provide. Prior to WIOA, CILs and information.
were required to provide the following core
must include the Docket No. FDA–
services: (1) Information and referral services; ADDRESSES: The public meeting will be 2017–N–0136 for ‘‘Public Meeting on
(2) independent living skills training; (3) peer held at the FDA White Oak Campus, Patient-Focused Drug Development for
counseling, including cross-disability peer 10903 New Hampshire Ave., Bldg. 31 Autism.’’ Received comments, those
counseling; (4) and individual and systems Conference Center, the Great Room (Rm. filed in a timely manner (see DATES),
advocacy. WIOA added additional 1503), Silver Spring, MD 20993–0002. will be placed in the docket and, except
‘‘transition and diversion’’ core services Entrance for the public meeting for those submitted as ‘‘Confidential
comprised of three components. It requires Submissions,’’ publicly viewable at
participants (non-FDA employees) is
CILs to:’’. https://www.regulations.gov or at the
through Building 1 where routine
Dated: February 24, 2017. security check procedures will be Division of Dockets Management
Daniel P. Berger, performed. For more information on between 9 a.m. and 4 p.m., Monday
Acting Administrator and Assistant Secretary parking and security procedures, please through Friday.
for Aging. refer to http://www.fda.gov/AboutFDA/ • Confidential Submissions—To
[FR Doc. 2017–04169 Filed 3–3–17; 8:45 am] WorkingatFDA/BuildingsandFacilities/ submit a comment with confidential
BILLING CODE 4154–01–P WhiteOakCampusInformation/ information that you do not wish to be
ucm241740.htm. made publicly available, submit your
You may submit comments as comments only as a written/paper
DEPARTMENT OF HEALTH AND follows: submission. You should submit two
HUMAN SERVICES copies total. One copy will include the
Electronic Submissions information you claim to be confidential
Food and Drug Administration with a heading or cover note that states
Submit electronic comments in the
‘‘THIS DOCUMENT CONTAINS
[Docket No. FDA–2017–N–0136] following way:
CONFIDENTIAL INFORMATION.’’ The
• Federal eRulemaking Portal: Agency will review this copy, including
Public Meeting on Patient-Focused
https://www.regulations.gov. Follow the the claimed confidential information, in
Drug Development for Autism;
instructions for submitting comments. its consideration of comments. The
Request for Comments
Comments submitted electronically, second copy, which will have the
AGENCY: Food and Drug Administration, including attachments, to https:// claimed confidential information
HHS. www.regulations.gov will be posted to redacted/blacked out, will be available
ACTION: Notice of public meeting; the docket unchanged. Because your for public viewing and posted on
request for comments. comment will be made public, you are https://www.regulations.gov. Submit
solely responsible for ensuring that your both copies to the Division of Dockets
SUMMARY: The Food and Drug comment does not include any Management. If you do not wish your
Administration (FDA, the Agency, or confidential information that you or a name and contact information to be
we) is announcing a public meeting and third party may not wish to be posted, made publicly available, you can
an opportunity for public comment on such as medical information, your or provide this information on the cover
Patient-Focused Drug Development for anyone else’s Social Security number, or sheet and not in the body of your
autism. Patient-Focused Drug confidential business information, such comments and you must identify this
Development is part of FDA’s as a manufacturing process. Please note information as ‘‘confidential.’’ Any
performance commitments made as part that if you include your name, contact information marked as ‘‘confidential’’
of the fifth authorization of the information, or other information that will not be disclosed except in
Prescription Drug User Fee Act (PDUFA identifies you in the body of your accordance with 21 CFR 10.20 and other
V). The public meeting is intended to comments, that information will be applicable disclosure law. For more
asabaliauskas on DSK3SPTVN1PROD with NOTICES
allow FDA to obtain patient posted on https://www.regulations.gov. information about FDA’s posting of
perspectives on the impact of autism on • If you want to submit a comment comments to public dockets, see 80 FR
daily life as well as patient views on with confidential information that you 56469, September 18, 2015, or access
treatment approaches for autism. do not wish to be made available to the the information at: https://www.gpo.gov/
DATES: The public meeting will be held public, submit the comment as a fdsys/pkg/FR-2015-09-18/pdf/2015-
on May 4, 2017, from 1 p.m. to 5 p.m. written/paper submission and in the 23389.pdf.
Registration to attend the meeting must manner detailed (see ‘‘Written/Paper Docket: For access to the docket to
be received by April 24, 2017 (see Submissions’’ and ‘‘Instructions’’). read background documents or the
VerDate Sep<11>2014 19:24 Mar 03, 2017 Jkt 241001 PO 00000 Frm 00079 Fmt 4703 Sfmt 4703 E:\FR\FM\06MRN1.SGM 06MRN1](https://thefederalregister.org/doc/82_FR_12652/page/2.svg)
Document Created: 2017-03-04 00:06:22
Document Modified: 2017-03-04 00:06:22
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice of correction. | |
| Contact | Corinna Styles, 202-795-7446. | |
| FR Citation | 82 FR 12610 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR